Chemical Structure (Ammonul 01)
Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 81665-204
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 81665-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Omnivium Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Ammonul 02)
This text appears to be a list of biochemical compounds including alpha-ketoglutarate, benzoate, glutamate, glutamine, phenylacetate, and phenylacetylglutamine. It seems to be a partial description related to biochemistry or metabolic pathways.*
Principal Display Panel (50 mL Vial Carton)
This text appears to be a description of a pharmaceutical product labeled as Sodium Phenylacetate and Sodium Benzoate Injection, 10%/10%, intended for intravenous use only. The product is provided in a single-dose vial and must be diluted before administration. Each mL contains 100 mg of sodium phenylacetate and 100 mg of sodium benzoate. The storage instructions mention keeping the product at 25°C (77°F) and allowing excursions between 15°C - 30°C. It is distributed by Omnivium Pharmaceuticals and includes a warning to administer it only through a peripheral IV. The text also states that the solution must be diluted with sterile, dextrose injection, 10% (D10W) before intravenous administration.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
